Gf Fund Management Co. Ltd.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
CIK
0002057060
Manager Name
Gf Fund Management Co. Ltd.
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions
Manager:
SEC
Search and click to pin securities to the top
Page 32 of 34
Annexon, Inc.
ANNX|03589W102
Shares:
2729(+21.9%)
Value:
$5.3M(-54.1%)
Foghorn Therapeutics Inc.
FHTX|344174107
Shares:
1424(+22.0%)
Value:
$5.2M(-5.6%)
Corvus Pharmaceuticals, Inc.
CRVS|221015100
Shares:
1594(+18.2%)
Value:
$5.1M(-29.8%)
Inhibrx Biosciences, Inc.
INBX|45720N103
Shares:
359(+18.1%)
Value:
$5.0M(+7.3%)
Y-mAbs Therapeutics, Inc.
YMAB|984241109
Shares:
1111(+18.2%)
Value:
$4.9M(-33.1%)
CARGO Therapeutics, Inc.
CRGX|14179K101
Shares:
1142(+18.2%)
Value:
$4.6M(-66.6%)
AC Immune SA
ACIU|H00263105
Shares:
2454(+18.1%)
Value:
$4.6M(-18.2%)
Voyager Therapeutics, Inc.
VYGR|92915B106
Shares:
1355(+18.1%)
Value:
$4.6M(-29.6%)
Tevogen Bio Holdings Inc.
TVGN|88165K101
Shares:
4207(+14.4%)
Value:
$4.5M(+20.0%)
Neurogene Inc.
NGNE|64135M105
Shares:
368(+17.9%)
Value:
$4.3M(-39.6%)
Neumora Therapeutics, Inc.
NMRA|640979100
Shares:
3883(+14.5%)
Value:
$3.9M(-89.2%)
Third Harmonic Bio, Inc.
THRD|88427A107
Shares:
1118(+18.2%)
Value:
$3.9M(-60.1%)
4D Molecular Therapeutics, Inc.
FDMT|35104E100
Shares:
1147(+18.1%)
Value:
$3.7M(-31.5%)
Solid Biosciences Inc.
SLDB|83422E204
Shares:
991(+18.1%)
Value:
$3.7M(+9.3%)
Tango Therapeutics, Inc.
TNGX|87583X109
Shares:
2665(+18.2%)
Value:
$3.7M(-47.6%)
COMPASS Pathways plc
CMPS|20451W101
Shares:
1261(+18.1%)
Value:
$3.6M(-10.7%)
Larimar Therapeutics, Inc.
LRMR|517125100
Shares:
1583(+18.1%)
Value:
$3.4M(-34.4%)
Silence Therapeutics plc
SLN|82686Q101
Shares:
1165(+18.0%)
Value:
$3.3M(-51.6%)
scPharmaceuticals Inc.
SCPH|810648105
Shares:
1242(+18.2%)
Value:
$3.3M(-12.2%)
Nkarta, Inc.
NKTX|65487U108
Shares:
1751(+18.1%)
Value:
$3.2M(-12.7%)